Inflammatory Bowel Disease Clinical Trial
Official title:
Resistance Training Intervention to Promote Lean Mass in Youth With IBD
Evaluate feasibility, safety, and preliminary estimates of resistance training (RT) efficacy to promote lean body mass accrual in patients with CD aged 14-18. This will be achieved by conducting a parallel 2-arm randomized-controlled pilot trial of RT compared to usual care. At weeks 0 (pre-treatment), 6 (mid-treatment), and 12 (post- treatment), feedback regarding safety, feasibility, and acceptability will be collected from participants through surveys and interviews. Magnitude of the effect size of the intervention on LBM, muscle strength, and health-related quality of life (HRQoL) will also be estimated.
Lean body mass (LBM) deficits are common in Crohn's Disease (CD) and persist beyond
achievement of remission. In a recent review of 21 studies with a total of 1,479 youth with
Inflammatory Bowel Disease (IBD), 93.6% of patients with CD showed deficits in LBM compared
to healthy controls. LBM deficits in CD are multifactorial though largely explained by
malnutrition. Even with weight restoration and remission however, youth with CD continue to
show deficits in LBM compared to healthy peers. Despite proportional deficits in fat and LBM
at baseline, weight restoration is explained by gains in fat without similar gains in LBM,
suggesting that additional mechanisms interact to maintain deficits such as low physical
activity (PA) or altered energy partitioning. Chronic LBM deficits can have deleterious
effects including decreased physical function, myopenia, metabolic dysregulation, increased
risk of infection, compromised peak bone mass accrual, and development of
osteopenia/osteoporosis. While some factors are not readily modifiable (e.g. underlying
disease mechanisms), targeting factors amenable to change may result in an increase in LBM
and thus improved health outcomes. Health behaviors, including exercise, are modifiable and
associated with the development of LBM. Resistance training (RT) has been associated with
improved LBM in youth with and without chronic illness. To our knowledge, no evidence-based
resistance training interventions have been developed to promote LBM accrual in pediatric CD.
The overarching aims of this proposal are to evaluate the safety, feasibility, and effects of
12 weeks of RT on LBM in youth with CD aged 14-18. Specifically we aim to:
Aim 1: Evaluate feasibility, safety, and preliminary estimates of RT efficacy to promote LBM
accrual in patients with CD aged 14-18. This will be achieved by conducting a parallel 2-arm
randomized-controlled pilot trial of RT compared to usual care. At weeks 0 (pre-treatment), 6
(mid-treatment), and 12 (post- treatment), feedback regarding safety, feasibility, and
acceptability will be collected from participants through surveys and interviews. Magnitude
of the effect size of the intervention on LBM, muscle strength, and health-related quality of
life (HRQoL) will also be estimated.
Positive findings would have broad implications for growth and long-term health outcomes
including bone disease and metabolic health in these young patients. More broadly, the
findings would have promising potential to be extended to patients with IBD across the
developmental and disease spectrum including youth with ulcerative colitis (UC) and adults
with IBD as they demonstrate similar LBM deficits. The proposed study will also provide
preliminary data to inform a evaluation through a larger trial.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03278912 -
Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
|
||
Terminated |
NCT00061282 -
Clotrimazole Enemas for Pouchitis in Children and Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05579392 -
A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis
|
N/A | |
Completed |
NCT03264690 -
Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
|
||
Recruiting |
NCT02861053 -
Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ?
|
N/A | |
Recruiting |
NCT02275676 -
Resting Energy Expenditure and Nutritional Status in IBD
|
N/A | |
Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT02161640 -
Vascular Dysfunction in Paediatric IBD
|
N/A | |
Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
Completed |
NCT01852760 -
Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound
|
N/A | |
Completed |
NCT01933867 -
Water-aided Colonoscopy in Inflammatory Bowel Disease Patients
|
N/A | |
Completed |
NCT01860651 -
Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease
|
N/A | |
Completed |
NCT01688557 -
Trial on Innovative Technologies in Colonoscopy
|
N/A | |
Completed |
NCT01692743 -
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
|
Phase 3 | |
Completed |
NCT01666535 -
Infliximab IBD Influenza Vaccine Study
|
N/A | |
Completed |
NCT01676324 -
FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT01557387 -
Real-time Diagnosis of Pseudopolyps During Colonoscopy
|
||
Completed |
NCT01981616 -
Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab
|
Phase 1 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01221818 -
A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
|
Phase 1 |